LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $147,218 | -35.1% | 26,478 | -14.4% | 0.00% | 0.0% |
| Q2 2023 | $226,938 | +86.8% | 30,918 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $121,508 | +83.8% | 30,918 | +47.8% | 0.00% | – |
| Q4 2022 | $66,101 | -15.3% | 20,918 | 0.0% | 0.00% | – |
| Q3 2022 | $78,000 | +20.0% | 20,918 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $65,000 | -40.4% | 20,918 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $109,000 | +7.9% | 20,918 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $101,000 | -45.7% | 20,918 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $186,000 | -2.6% | 20,918 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $191,000 | -52.0% | 20,918 | -14.3% | 0.00% | -50.0% |
| Q1 2021 | $398,000 | – | 24,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,321,403 | $20,869,000 | 0.71% |
| Integral Health Asset Management, LLC | 30,000 | $274,000 | 0.08% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $7,392,000 | 0.03% |
| Orbimed Advisors | 113,500 | $1,035,000 | 0.01% |
| Alyeska Investment Group, L.P. | 85,360 | $778,000 | 0.01% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,287,289 | $20,105,000 | 0.00% |
| Laurion Capital Management LP | 20,918 | $191,000 | 0.00% |
| FMR LLC | 2,037,831 | $18,585,000 | 0.00% |
| BlackRock Inc. | 17,999 | $164,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 38 | $0 | 0.00% |